TY - JOUR
T1 - Promotion of regular oesophageal motility to prevent regurgitation and enhance nutrition intake in long-stay ICU patients. A multicenter, phase II, sham-controlled, randomized trial
T2 - The PROPEL study
AU - Heyland, Daren K.
AU - Marquis, Francois
AU - Lamontagne, Francois
AU - Albert, Martin
AU - Turgeon, Alexis F.
AU - Khwaja, Kosar A.
AU - Garland, Allan
AU - Hall, Richard
AU - Chapman, Martin G.
AU - Kutsiogannis, Demetrios J.
AU - Martin, Claudio
AU - Sessler, Daniel I.
AU - Day, Andrew G.
N1 - Publisher Copyright:
Copyright © 2020 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.
PY - 2020
Y1 - 2020
N2 - Objectives: To evaluate the effect of esophageal stimulation on nutritional adequacy in critically ill patients at risk for enteral feeding intolerance. Design: A multicenter randomized sham-controlled clinical trial. Setting: Twelve ICUs in Canada. Patients: We included mechanically ventilated ICU patients who were given moderate-to-high doses of opioids and expected to remain alive and ventilated for an additional 48 hours and who were receiving enteral nutrition or expected to start imminently. Interventions: Patients were randomly assigned 1:1 to esophageal stimulation via an esophageal stimulating catheter (E-Motion Tube; E-Motion Medical, Tel Aviv, Israel) or sham treatment. All patients were fed via these catheters using a standardized feeding protocol. Measurements and Main Results: The co-primary outcomes were proportion of caloric and protein prescription received enterally over the initial 7 days following randomization. Among 159 patients randomized, the modified intention-to-treat analysis included 155 patients: 73 patients in the active treatment group and 82 in the sham treatment group. Over the 7-day study period, the percent of prescribed caloric intake (± se) received by the enteral route was 64% ± 2 in the active group and 65% ± 2 in sham patients for calories (difference, -1; 95% CI, -8 to 6; p = 0.74). For protein, it was 57% ± 3 in the active group and 60% ± 3 in the sham group (difference, -3; 95% CI, -10 to 3; p = 0.30). Compared to the sham group, there were more serious adverse events reported in the active treatment group (13 vs 6; p = 0.053). Clinically important arrhythmias were detected by Holter monitoring in 36 out of 70 (51%) in the active group versus 22 out of 76 (29%) in the sham group (p = 0.006). Conclusions: Esophageal stimulation via a special feeding catheter did not improve nutritional adequacy and was associated with increase risk of harm in critically ill patients.
AB - Objectives: To evaluate the effect of esophageal stimulation on nutritional adequacy in critically ill patients at risk for enteral feeding intolerance. Design: A multicenter randomized sham-controlled clinical trial. Setting: Twelve ICUs in Canada. Patients: We included mechanically ventilated ICU patients who were given moderate-to-high doses of opioids and expected to remain alive and ventilated for an additional 48 hours and who were receiving enteral nutrition or expected to start imminently. Interventions: Patients were randomly assigned 1:1 to esophageal stimulation via an esophageal stimulating catheter (E-Motion Tube; E-Motion Medical, Tel Aviv, Israel) or sham treatment. All patients were fed via these catheters using a standardized feeding protocol. Measurements and Main Results: The co-primary outcomes were proportion of caloric and protein prescription received enterally over the initial 7 days following randomization. Among 159 patients randomized, the modified intention-to-treat analysis included 155 patients: 73 patients in the active treatment group and 82 in the sham treatment group. Over the 7-day study period, the percent of prescribed caloric intake (± se) received by the enteral route was 64% ± 2 in the active group and 65% ± 2 in sham patients for calories (difference, -1; 95% CI, -8 to 6; p = 0.74). For protein, it was 57% ± 3 in the active group and 60% ± 3 in the sham group (difference, -3; 95% CI, -10 to 3; p = 0.30). Compared to the sham group, there were more serious adverse events reported in the active treatment group (13 vs 6; p = 0.053). Clinically important arrhythmias were detected by Holter monitoring in 36 out of 70 (51%) in the active group versus 22 out of 76 (29%) in the sham group (p = 0.006). Conclusions: Esophageal stimulation via a special feeding catheter did not improve nutritional adequacy and was associated with increase risk of harm in critically ill patients.
UR - http://www.scopus.com/inward/record.url?scp=85079341302&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85079341302&partnerID=8YFLogxK
U2 - 10.1097/CCM.0000000000004176
DO - 10.1097/CCM.0000000000004176
M3 - Article
C2 - 31904685
AN - SCOPUS:85079341302
SN - 0090-3493
SP - E219-E226
JO - Critical Care Medicine
JF - Critical Care Medicine
ER -